Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Nov 14, 2021; 27(42): 7376-7386
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7376
Table 1 Comparison of patients’ demographics and clinical manifestations before corticosteroid treatment

All (n = 285)
Diffuse type (n = 214)
Focal type (n = 71)
P value
Sex230 (80.7)179 (83.6)51 (71.8)0.03
Age62 (54, 68)62 (55, 68)59 (53, 68)0.12
Follow-up time (mo)26 (12, 51)28 (13, 51)21 (9, 51)0.13
Symptoms
Abdominal pain73 (26.0)51 (23.8)22 (31.0)0.23
Jaundice106 (37.2)81 (37.8)25 (35.2)0.69
Number of involved organs11 (1, 2)1 (1, 2)1 (1, 2)0.47
Laboratory tests
ALT (U/L) (9-50)47 (18, 133)64 (18, 184)30 (15, 83)0.01
TBil (μmol/L) (5.1-22.2)20.6 (12.2, 55.6)21.4 (12.9, 68.7)14.5 (11.6, 45.2)0.08
IgG (mg/dL) (700-1700)1590 (1140, 2070)1630 (1130, 2140)1510 (1130, 1760)0.37
IgG4 (mg/dL) (8-140)558.0 (280.5, 1270.0)605.5 (253.5, 1457.5)458.0 (301.0, 1050.0)0.26
CA 19-9 (U/L) (0-34.0)20.3 (7.9, 61.0)23.4 (10.5, 74.1)12.6 (6.7, 36.5)0.01